| Logo | Name | Σ | Employees |
|---|---|---|---|
|
Pioneering innovative treatments for chronic inflammatory sino-nasal diseases. Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life. Type: Startup Activities: deeptech healthtech |
2 | 76 |
|
ClimateHack is where impact-driven Founders and Funders come to meet, learn and build together. Join us at a ClimateHack Meetup to connect with your local community. Subscribe to ClimateHack weekly to stay ahead of the curve on the latest funding, partnerships and news in ClimateTech. Type: Media |
53 | 18 |
|
Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - innovative startups and SMEs. The objective of the association is to promote the development of the technology and innovation ecosystem in Italy, working closely with institutions. The contents of the Italian Tech Alliance disseminate news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. The following currently sit on the Board of Directors: Alessio … Type: NGO, Think-tanks, Ed, & Culture Activities: it services |
24 | 22 |
|
Follow all the economic news from Toulouse and Haute-Garonne in an instant. La Gazette du Midi is a weekly economic and legal information magazine based in Toulouse. Created in 1881, the newspaper is authorized to publish judicial and legal announcements in Haute-Garonne. It is part of the ForumEco group. Type: Media |
165 | 11 |
|
We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, Law, Designs, Copyright, Unified Patent Court, and EPO 55 similar entities Type: SMB Activities: legaltech |
10 | 640 |
|
Medical-Grade AI for Radiology Fraudulent Recruitment Notice : It has come to our attention that third parties are conducting fraudulent recruitment and onboarding processes using notably the domain Gleamer.us and impersonating Gleamer personnel. Gleamer.us is not an authorized domain of Gleamer, and any communication originating from it is fraudulent. The only official domain used by Gleamer for its website and email communications is Gleamer.ai. If you believe you have been targeted by this scam, please refrain from providing any personal information and notify us at corporate@gleamer.ai. Gleamer is a French company shaping the future of medical imaging to support better … Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech Technologies: A.I. |
37 | 123 |
|
Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 15 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 250,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: Media |
33 | 4,332 |
|
We back tech founders solving the world's biggest problems. Seed fund supporting entrepreneurs solving the world's biggest problems. There’s a sea change coming in business as big as the shift from desktop to the cloud, or from web to mobile. Fifty Years supports the entrepreneurs heralding in the new economic renaissance. Read our view here: http://techcrunch.com/2015/10/02/impact-is-the-new-mobile/ 32 similar entities Type: Startup Activities: it services Technologies: SaaS |
42 | 41 |
|
Consulting for medtech firms : - Data strategy - Quality & Regulatory - Clinical & Reimbursement - Go-to-market strategy MD101 was founded to assist medical device companies in developing and bringing products to market, accelerating time-to-market, and ensuring compliance with regulatory standards. With its large network of experts, MD101 provides mastery in a myriad of medical devices and is equipped to handle whatever challenge a manufacturer is facing, whether it is data strategy, quality assurance, regulatory affairs, clinical affairs, reimbursement strategy, or international business development. At MD101, we bring you the power of our unique value proposition, focused on healthcare, … Type: Startup Activities: consulting Technologies: Synthetic Biology |
27 | 19 |
|
Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward. GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology. Launched as Google Ventures in 2009, GV oversees more than $10 billion in assets under management. Our operating partners support founding teams at every stage of company-building across executive talent, design, communications, and marketing. GV is a non-strategic venture capital firm that invests independently from its sole limited partner, Alphabet. We connect startups with Google and Alphabet companies, providing unique access to the … Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Cybersecurity |
70 | 509 |
|
The Wall Street Journal
Winner of 40 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: Media |
271 | 14,722 |
|
A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … 46 similar entities Type: SMB Activities: deeptech Technologies: New Materials Bio sourced materials |
15 | 218 |
|
The Unicorn Trophies aim to identify French companies which have strong growth potential and which in the next 5 years could be valued beyond one billion euros. Type: Incubators & VCs |
96 | 1 |
|
BIOTECH AGORA
Familiarizing investors with companies offering breakthrough innovations in the field of Life Sciences. Biotech Agora aims to introduce the specialist or non-specialist public to companies in the field of Biotech and more generally in the field of Life Sciences which offer breakthrough innovations. Our DNA: • Improve visibility and understanding of the sector • Highlight cutting-edge companies, listed and unlisted • Contribute to financing innovation • Prioritize discussions with managers and encourage discussions between investors • Put the human adventure at the heart of investment • Support companies and expand their shareholding Type: NGO, Think-tanks, Ed, & Culture Activities: fintech |
46 | 2 |
|
Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of press and communication. Specializing in press relations and financial communications, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Since March 2025, the Ulysse Communication teams have joined the Maarc agency! More information on www.maarc.fr Press relations, Financial communication, Finance, … Type: Media |
74 | 4 |
|
Investment magazine - investments. Magazine specialized in investment and investments. We talk about finance, economics, entrepreneurship, real estate... Nearly 3 million visits in 2023 and on newsstands from fall 2024. Advertising agency: Kétil Media 2023: Nominated for the Gold and Silver Feathers of Economy and Law prize for the article "ISR: “responsible" SCPIs are more efficient, but..." 2022: Nominated for the article prize by MédiaPro (formerly Presse Pro), association for the promotion of professional information for the article "GameStop: when amateur traders shake the financial system" Real estate, personal finance, finance, stock market, life insurance, savings, online press service, media, … Type: Media |
15 | 7 |
|
The strategic information media dedicated to the digital transformation of health industries. mind Health is a strategic information media which offers daily monitoring of news in the health sector and each week in-depth analytical articles enriched by data. Its mission is to decipher the transformations of the health sector and industries through its economic, technological, regulatory and political issues. mind Health is aimed at all players in the value chain in the health ecosystem: pharmaceutical and medical device industries, electronics, IT and telecoms, mutual funds and insurance, public and private healthcare provision, service providers, etc. 7 similar entities Type: Startup Activities: healthtech Technologies: Data Analytics |
123 | 3 |
|
Independent financial advisory firm | DAF CFO Part-Time | Transaction Services | Business Plan | B Corp 2CFinance transforms ambitions into successes. We support entrepreneurs and investors at every stage of their journey (start-up, growth, restructuring). With high-level financial expertise and true entrepreneurial DNA, we do much more than advice: we create value. We operate in 3 professions: part-time financial management, transaction services and business modeling. Our strength: combining operational know-how, strategic vision and sectoral flexibility. Our team of +100 employees is distributed between our offices in Paris, Lille, Lyon, Aix-en-Provence, and Nantes to support you throughout the country, as … 60 similar entities Type: Startup Activities: fintech |
88 | 111 |
|
Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: Startup Activities: healthtech deeptech manufacturing biotech Technologies: Affective Computing A.I. Solar Technologies Synthetic Biology Wireless |
10 | 9 |
|
AI Serving Cardiology Cardiologs is a medical technology company on a mission to democratize expert cardiac care through medical-grade artificial intelligence. Machine Learning, Big Data, MedTech, Cardiology, Artificial Intelligence, ECG analysis, Holter analysis, and SaaS Type: Startup Activities: healthtech Technologies: A.I. A.I. - Machine Learning SaaS |
22 | 65 |
|
Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. |
30 | 46 |
|
Europe’s Day-One Impact Launchpad At AFI Ventures, we are committed to backing the most promising seed & pre-seed impact entrepreneurs. From climate action to healthy living, we partner with every visionary that shares the ambition of deep, at-scale impact. We are investing up to 500k€ in 1 to 2 companies every month. AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. impactinvesting, capitalrisque, VC, impact, startup, fonds, seed, financement, entrepreneurship, and socialbusiness Type: Incubators & VCs Activities: fintech |
24 | 6 |
|
Empower the body, cure the disease Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific … 10 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology |
6 | 12 |
|
Bioxodes is a clinical-stage biotech company developing therapeutics for patients with (thrombo)inflammatory diseases. Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs. Hemorrhagic stroke, Intracerebral hemorrhage, Antithrombotic, Coagulation Factor XI, Coagulation Factor XII, Thrombosis, and Neuroinflammation 27 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
3 | 12 |
|
Frontier models for all molecules of life. We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today. 43 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: A.I. Generative A.I. |
6 | 23 |
|
We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a biotech company focused on developing small molecule inhibitors of oncogenic transcription factors. The company has a particular focus on drugging cell lineage-specific transcription factors that are known cancer dependency genes. Built on a deep understanding of transcriptional regulation and the biophysics of intrinsically-disordered proteins (IDPs), Nuage has developed technologies that enable the ‘capture’ of IDPs in higher-order, self-assembled states that present binding pockets that render these proteins amenable to small molecule drug discovery. This represents a game-changing advance that has led to the identification of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
6 | 25 |
|
The digital boiler room that does more. The energy-saving pilot for all boiler rooms. We don't just digitize your boiler rooms, we automate and optimize the entire operation of your portfolio and ensure a smooth transition to regenerative systems. For maximum efficiency and sustainability in the housing industry. Want to operate your systems intelligently? Save money, energy and CO2? With our software, your systems optimize, control, analyze and monitor themselves: * Analysis & optimization - continuous and holistic * Semi-automated or fully automated operations management - sit back and save * For conventional existing systems, complex new energy systems and … 27 similar entities Type: Startup Activities: cleantech greentech it services Technologies: A.I. A.I. - Machine Learning Solar Technologies |
12 | 105 |
|
Future-shaping fats and oils. Sustainably made. 🔴 We are ÄIO, a deep-tech startup from Estonia with a mission to transform fats and oils into sustainable, climate-positive ingredients. Our proprietary precision fermentation platform uses robust yeast strains to upcycle wood and food industry side-streams into functional microbial oils. By leveraging local biomass and industrial residues, we offer alternatives to palm, coconut, and animal fats, without depending on arable land, seasonal crops, or deforestation-prone agriculture. Founded in 2022 as a TalTech spin-off, ÄIO has rapidly scaled from lab experiments to 10,000 L pilot production in 2024 and 100,000 L in 2025. Our … Type: Startup Activities: foodtech greentech Technologies: Decarbonization |
13 | 27 |
|
The next generation of therapeutics for bleeding and thrombotic disorders Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
3 | 85 |
|
French representation of the Technion, Israel Institute Of Technology The Technion France's mission is to promote the Technion, Israel Institute of Technology, in scientific, industrial and economic circles and to publicize the Technion's achievements and projects in the fields of scientific and technological research. In addition, it intends to encourage the establishment of close relationships between these environments and all the scientists, teachers and students of the Technion, for the development of cooperation on projects of common interest. It also aims to increase the number of events and conferences in France by inviting professors specializing in Israel. Finally, it provides … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech |
72 | 9 |
|
Your preferred biomanufacturing partner through cell-free enzyme technologies Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the efficiency of … 62 similar entities Type: Startup Activities: biotech cleantech deeptech energytech greentech Technologies: Decarbonization |
9 | 39 |
|
Part of Innovative Beauty Group (IBG), we are a global creative agency crafting the brands of tomorrow since 1988. Part of Innovative Beauty Group (IBG). Centdegrés is an international agency of brand intelligence and creation. Our mission is to generate value for our clients: create beautiful brands out of nothing, and render existing brands more sought after and more in tune with their era. With this in mind, we redefine their sense and redesign their shape: brand platform, visual identity, artistic direction, product design, and retail spaces. We cater to big groups, SMEs, start-ups, and international and local structures led … 54 similar entities Type: SMB Activities: martech Technologies: SaaS |
18 | 55 |
|
Reference information for the pharmaceutical sector Since 1992, economic, political and regulatory news from players in the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Report on major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech |
84 | 85 |
|
Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences 218 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
22 | 18 |
|
We are the French medical technology companies, we innovate every day for patients! Created in 2013, MedTech in France currently brings together more than 40 French companies in the health MedTech sector. and telemedicine, optical technologies, surgical robotics, and even medical imaging. The Association develops concrete solutions to promote market access, innovations and highlight French excellence in medical technologies. It has also set itself the mission of creating French champions internationally. MedTech in France has set itself a triple ambition: > provide medical solutions for patients and caregivers > bring economic and organizational benefits to the health system > and … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech |
42 | 7 |
|
The right financing at the right time! Talas Partners is your partner of excellence to propel your company's innovation towards new horizons. Who are we ? Much more than a simple innovation financing consultancy firm, we become your partner to achieve your entrepreneurial objectives and lead you towards success. Our passion is to transform each innovative project into a successful entrepreneurial success. Our Mission We have a clear mission: to help Startups and SMEs develop their businesses by mobilizing public or private financing. Our Support Present in the innovation ecosystem for a very long time, we guide you in all … Type: Incubators & VCs |
8 | 2 |
|
The only multi-professional network, bringing together service companies involved in medical information and health communications Communities, Expertise, Opportunities The FNIM – National Federation of Medical Information is the only multi-professional network in France, bringing together service companies engaged in medical information and health communication. In a context of profound transformations – evolution of the healthcare system, acceleration of digital technology and AI, regulatory pressure, new uses of information, CSR issues, circulation of fake news – the FNIM and its members support stakeholders in the health ecosystem in understanding and anticipating these changes. 15+ professions, 60+ companies The FNIM brings together … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: A.I. |
29 | 8 |
|
Fundraising I M&A Kickston is a merchant bank that supports entrepreneurs in their fundraising and M&A operations. Industries: Consumer & B2B Tech • Fundraising: 2 to 10M€ • Transfer: Operations up to €15M Are you interested in our approach? Contact us! contact@kickston.co Type: Incubators & VCs |
40 | 6 |
|
FUSACQ is a marketplace dedicated to experts in mergers and acquisitions, investment funds and private investors, buyers who are legal entities and individuals, and business leaders wishing to sell their business. 1 company is sold every day thanks to the portal (https://www.fusacq.com) which offers: SERVICES TO PROMOTE TRANSMISSION RESUME OPERATIONS - 2500 announcements of companies for sale or looking to acquire - 2000 investment fund participations - 450 CVs of natural person buyers - 600 experts involved in all stages of an operation - training in business takeover and external growth - a company valuation basis ALL THE NEWS ON … Type: Incubators & VCs Media |
114 | 13 |
|
Smart brevity. We are a new media company delivering vital, trustworthy news and analysis in the most efficient, illuminating and shareable ways possible. We offer a mix of original and smartly narrated coverage of media trends, tech, business and politics with expertise, voice AND smart brevity — on a new and innovative mobile platform. At Axios — the Greek word for worthy — we provide only content worthy of people's time, attention and trust. Careers: https://www.axios.com/careers |
124 | 616 |
|
Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Fribourg, Switzerland March 17-19, 2026 Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, Polymerisation, Biomass pretreatment, … Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech greentech Technologies: New Materials |
61 | 2 |
|
Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of … 34 similar entities Type: SMB Activities: biotech Technologies: Decarbonization |
15 | 43 |
|
From the movement of knowledge to the therapeutic approaches of tomorrow The Vision Institute is one of the largest integrated research centers on vision diseases in Europe. Designed as a place for gathering and exchange, it brings together fundamental, clinical and industrial research on the same site, thus promoting the sharing of concepts and techniques, the meeting of complementary skills and expertise and the emergence of new avenues of research. Researchers, doctors and manufacturers work together to discover and validate new therapies, preventive solutions, as well as technologies to compensate for visual impairment. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech |
39 | 279 |
|
Crédit Mutuel Innovation
Crédit Mutuel Innovation is the subsidiary specializing in venture capital investments of Crédit Mutuel Equity (€4 billion in capital managed). It invests in equity tickets of between €1 and €20 million in innovative deeptech, digital and life sciences companies. Crédit Mutuel Innovation allows entrepreneurs to develop their growth potential by connecting them to companies in its ecosystems. Because it takes more than 5 years to create a world leader, Crédit Mutuel Innovation invests its own capital sustainably and builds long-term relationships with the entrepreneurs it supports. Type: Incubators & VCs |
64 | 17 |
|
1st French network of growth entrepreneurs, bringing together companies of all sizes and from all sectors. A network of nearly 500 entrepreneurs! Our 500 entrepreneurs are committed to building an entrepreneurial society that combines meaning and growth. A society in which each actor - civil society, associations, entrepreneurs - can create solutions to the problems encountered and address the challenges our society faces. Entrepreneurship, Lobbying, Entrepreneur, Networking, and Responsible Growth Type: NGO, Think-tanks, Ed, & Culture Activities: entrepreneurship |
71 | 100 |
|
Toute l'actualité et les bases de données du Corporate Finance et Private Equity www.cfnews.net - Realtime Corporate Finance news and databases (M&A, Venture, LBO...) - Articles et bases de données en continu sur le Corporate Finance - (Fusions/acquisitions, capital risque, LBO ...) CFnews s'adresse aux dirigeants, DAFs ainsi qu'aux investisseurs, banquiers et avocats d'affaires, conseils due diligence impliqués dans des opérations de corporate finance sur le marché français. Articles Corporate Finance et Private Equity, M&A, LBO, Levées fundraising, Référentiel historique archives recherche deals transactions, non-coté, Fusions acquisitions, Capital-Risque Venture, capital-investissement, Capital Développement, ESG, CGP, immobilier, and infrastructures Type: Media |
108 | 1 |
|
The bank we want to recommend. Launched in 1998, BoursoBank is a pioneer and leader in its main activities: banking and online economic and financial information. With development centered around new customer expectations, simplicity and efficiency, but also security and reduced fees, BoursoBank strengthens its position as a major banking player in France each year. - Complementary and attractive professions in complete synergy - An ability to stay ahead of consumer behavior, with a focus on quality of service and customer satisfaction - A socially committed and environmentally responsible employer, certified B Corp Banking, Markets, and Media Type: Large company Activities: fintech |
166 | 1,205 |
|
1st weekly specialist information, biotech, medtech, e-health, finance published by Jacques Bernard Taste PRESENTATION The weekly Biotech Finances letter approaches from an economic and financial angle all questions linked to the development of the biotechnology sector and more broadly life sciences. Our target readership is mainly made up of biotechnology companies focused on health and the development of new therapies and new disease treatments, pharmaceutical companies (big pharma and other laboratories), investors, business angels, investment funds, venture capital, specialized in the biotech sector, institutions, legal advisors, development experts, and service providers and equipment suppliers. Our articles deal with research and … Type: Media |
48 | 10 |
|
FoodTech Weekly
Join 3,000+ founders, investors and other ecosystem actors to get the latest FoodTech and Food news. News on FoodTech, food, and society. foodtech, agtech, climatetech, food, food policy, startups, VC, research, and agriculture Type: Media |
35 | 2 |
|
Agile Capital Markets
Agile Capital Markets is a healthcare investment bank with a team of former healthcare CEOs/CFOs and VC/PE analysts. Agile Capital Markets delivers tailored financial services for healthcare companies and investors. We focus on four business lines: Fundraising, Mergers & Acquisitions, Licensing, and Investor Services. We empower biotech, medtech, digital health, pharmaceutical companies, CROs/CDMOs, other healthcare service companies and investment funds to thrive by facilitating impactful transactions and unlocking growth opportunities, all backed by our deep expertise in healthcare. Agile Capital Markets in a nutshell: - €1.2Bn+ transactions secured - 18 transactions in the last 24 months - size of transactions … Type: Incubators & VCs |
26 | 8 |
|
ESCP - MSc Biopharmaceutical Management
Master of Science in Biopharmaceutical Management of ESCP The purpose of the Master of Science in Biopharmaceutical Management (MsM) is to train future managers of the pharmaceutical and medical device industries, consulting firms, financial institutions and biotechnology companies to operate in a radically changing environment in which internationalisation on one hand, digitalization, technological innovation and convergence on the other, are major factors of disruption. The program is held on the Paris and London campuses in order to make the most of international best practices in the field of healthcare and life sciences. Closely linked through a partnership with major pharmaceutical … 25 similar entities Type: SMB Activities: healthtech Technologies: Data Analytics |
21 | 7 |
|
Rare but not alone The mission of Fondation Ipsen, under the aegis of Fondation de France, is to improve Rare Disease diagnosis and patients' day-to-day lives. Discover our program, books, webinars, training, videos and podcasts allowing to advance rare disorder detection. new treatments, Education, Diseases, Progress, Well being, Patients, Longevity, Science, Medicine, Equity in Society, SciCom, and rare disease Type: Media Activities: healthtech deeptech |
12 | 10 |
|
We are a biology-powered company enabling businesses to make superior products with nature Insempra is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products. For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to drive the regenerative revolution to manufacture at scale in collaboration with nature. Led by a hand-picked team of biologists, technologists and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. … |
8 | 44 |
|
Industrial organ on chip technology We are developing organs on a chip that are miniature organ replicas outside human body. We are focusing on microbiome and gut on on chip that allows to develop drugs more effective and study biological processes. We are also developing easy to use instrument to run experiments on the chips. 43 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
4 | 15 |
|
Type: Startup Activities: entertainment |
6 | 135 |
|
First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. 7 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology |
1 | 181 |
|
We’re Parkinson’s UK, the charity that’s here to support every Parkinson’s journey. Every step of the way. We’re Parkinson’s UK. The charity that’s here to support every Parkinson’s journey, every step of the way. We don’t wait for change, we make it happen. Campaigning for better health and care. Funding research into groundbreaking new treatments. Running life-changing support services. We’re a powerful community united by one mission: improving life with Parkinson’s. health care, medical research, campaigning, fundraising, and charity Type: SMB Activities: healthtech deeptech fintech biotech silvertech Technologies: Synthetic Biology |
24 | 737 |
|
“The greatest investment we can ever make is to invest our life in the life of someone else.” Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States. The firm focuses on companies developing first- or best-in-class therapeutics to address major unmet medical needs. Bioqube builds balanced portfolios and supports companies from inception through early clinical milestones. For more information, please visit www.bioqubeventures.com Bioqube Ventures is dedicated to funding therapeutic innovations: - A life sciences venture capital fund – dedicated to advancing exciting science in European and US ecosystems to breakthrough therapies for … Type: Incubators & VCs |
3 | 19 |
|
The global pharmaceutical open-access capability and technology platform WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs … Type: Large company |
28 | 4,188 |
|
BioCentury gives biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events. When you subscribe to BioCentury, our team of Ph.D.s, analysts and industry experts become an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you the who’s who in the industry. Watch the latest episodes of The BioCentury Show on YouTube www.biocenturyyoutube.com Subscribe to the "BioCentury This Week" … 6 similar entities Type: SMB Activities: fintech Technologies: Data Analytics |
42 | 82 |
|
Innovation in health: where research turns into life The Barcelona Science Park is one of Europe's leading ecosystems in research, technology transfer and innovation with more than 100,000m2 built and around 3,453 professionals working in 120 entities mainly in the health sector: pharmaceuticals, biotechnology, medical technologies, food and cosmetics. 3 similar entities Type: SMB Activities: deeptech |
38 | 115 |
|
Cellulose based functional material solutions Seprify provides cellulose material solutions to enable businesses greener product formulations. 28 similar entities Type: SMB Activities: greentech cleantech Technologies: New Materials |
10 | 21 |
|
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: Large company Activities: deeptech healthtech biotech |
23 | 44,748 |
|
Transforming Lives Through the Science of Food Tate & Lyle's purpose, Transforming Lives Through the Science of Food, inspires everything we do. Whether it’s by making food and drink healthier and tastier; continuously improving how we work; promoting a safe working environment; or making a difference to our local communities, we believe we can successfully grow our business and have a positive impact on society. What is it we do? Simply put, we make healthy food tastier and tasty food healthier. Our work is driven by consumer health needs and trends, governments desire to build and support healthy communities, and … Type: Large company |
17 | 4,765 |
|
L'Interclubs Numérique des Alumni des Grandes Écoles & Universités The G9 + Institute is a plural and apolitical think tank, promoting digital development in France. Federating 24 graduate communities of universities and colleges, and 50000 alumni, the G9 + Institute is one of the reference think tanks of digital for more than 22 years. Engaged in its historical mission of consultative source of proposals, the G9 + Institute wants to allow its members and friends to confront their ideas, deepen them and make them known. It brings an investigative, constructive and audacious light by publishing white papers and organizing about … Type: NGO, Think-tanks, Ed, & Culture Activities: it services |
69 | 13 |
|
We are the first believers The world produces a handful of world-class entrepreneurs a year. We are entrepreneurs too, and have designed from scratch the ideal partner for these unique people. A meaningful check at Day One, often even before the company actually exists. A responsive, reliable and knowledgeable counterpart with aligned interests. A long-term relationship we hope will last a decade. We are Frst. -- €200m+ AUM invested at day one in 50+ companies to date. Full portfolio on frst.vc Type: Incubators & VCs |
17 | 14 |
|
MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these … 98 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology |
4 | 4 |
|
We fund ambitious, cohesive teams with stellar learning and execution curves. Investing in 2 to 3 startups per week, all over the world. Type: Incubators & VCs |
81 | 25 |
|
Empowering visionary entrepreneurs Chausson Partners is a leading venture & early growth advisory firm, providing deal making and equity story advice, as well as devoted support to inspiring founders. We helped shape +350 deals, and raise $1Bn. Our community of clients include leadership teams funded by Accel, Balderton, Alven and other top venture investors. Fundraising, Corporate Finance, Venture Capital, investment banking, equity rounds, M&A, Series A, Series B, Equity Financing, PE, Build up, Early growth, Exit, and Tech advisory Type: Incubators & VCs |
38 | 18 |
|
Closed
KREAXI
Financing partner for innovative start-ups KREAXI is one of the top French leaders in seed and venture capital, with €150m under management, 550 companies invested since last 30 years (of which 27 went public), 60 active portfolio companies, with a team of 16 persons based in Lyon and Paris. Type: Incubators & VCs |
52 | 5 |
|
Think Tank focused on transforming healthcare through the use of health data for the benefit of patients and citizens. The Healthcare Data Institute is a Think Tank, a collaborative structure, dedicated to the transformation of the healthcare system through the scientific and economic use of health data for the benefit of healthcare system stakeholders, patients, and citizens. healthcare, think tank, data mining, machine learning, Health Data, Artificial Intelligence, and Blockchain Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech it services |
90 | 11 |
|
Heart-led venture capital for global game changers Alven is an independent early-stage venture capital firm with over $500m under management and a successful track record of backing more than 130 startups over 20 years. Our mission at Alven consists in supporting the long-term success of European category-defining startups with global reach, starting at Series A or Seed stage. Alven’s sectors of interest include notably B2C/B2B marketplaces, productivity and dev tools, vertical AI platforms, consumer social & entertainment, B2C financial services and wellness brands. Examples of past or current investments PRODUCTIVITY SOFTWARE: Akeneo - Bime Analytics - Dataiku - Georges.tech - … Type: Incubators & VCs Activities: fintech it services Technologies: SaaS Blockchain/Cryptocurrency A.I. |
58 | 32 |
|
ACCELERATING DEVELOPMENT FROM BIOSCIENCES TO BIOPRODUCTION An expert in managing research and development projects (R&D), TWB* supports the industry to develop innovative and sustainable solutions for the benefit of the planet and people. TWB sets up and conducts R&D projects in collaboration with public laboratories and industrials, supports the development of start-ups by offering them accommodation on its premises in a state-of-the-art scientific and technological environment and encourages breakthrough innovation. By bringing together researchers, entrepreneurs, financiers, institutions and industry, TWB integrates and enhances all skills and expertise and creates synergies, while simplifying the contractual relationship. This unique model accelerates the … |
50 | 69 |
|
High density and high resolution graphene intelligent neural systems for BCI therapeutics *FDA Breakthrough Designation* High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology Nanotechnology, Biotechnology, Medical Devices, Brain Modulation, Closed Loop, AI, Neural Interfaces, Bioelectronics, Deep Tech, and Brain Computer Interface Therapeutics (BCI- Tx) 10 similar entities Type: Startup Activities: deeptech nanotech healthtech Technologies: A.I. |
20 | 110 |
|
Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … 43 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
12 | 213 |
|
Karista
Karista is a European VC firm investing in game changers from scratch to success. Karista is an early-growth investment firm backing ambitious entrepreneurs across Europe. For nearly 25 years, we have supported over 100 startups and scale-ups, many of which have achieved successful exits through acquisitions or listings on major exchanges, including Nasdaq. Our current strategy focuses on two key sectors: HealthTech and Space, Defence & Security, executed through dedicated funds and specialized teams with deep domain expertise. We primarily invest in early-growth opportunities, while selectively supporting early-stage moonshot projects with transformative potential. Trusted by leading institutional investors, financial groups, … Type: Incubators & VCs |
14 | 15 |
|
The leading information service for financial professionals in France. AGEFI is the leading information service for financial professionals in France. AGEFI relies on the 1st financial editorial team made up of 50 journalists with financial expertise, covering all financial sectors: Asset Management, Private Equity, Institutional Investors, Cash & Risk, Heritage. On a daily basis, our journalists analyze, decipher and deepen the news and offer our readers unique information with very high added value (alerts, articles, analyses, in-depth reports, etc.) essential to their activity. AGEFI, as a facilitator of the communities that make up finance, organizes more than 30 reference events. … Type: Media |
259 | 187 |
|
No one leaves Suresnes who often does not return there SURESNES, AN INNOVATIVE AND SUSTAINABLE CITY Located on the outskirts of Paris, on the edge of the Bois de Boulogne, Suresnes is a dynamic town in the west of Paris which extends from Mont-Valérien, a place steeped in history, to the banks of the Seine. From "the Garden City", a model of social urban planning built between the wars, to the recent eco-exemplary district, "Ilot Sisley", its 49,000 inhabitants bring the six districts that make up the City to life harmoniously. A wine-growing village in the Middle Ages, Suresnes still … Type: Public |
97 | 361 |
|
La villa numeris
Think digital, make it real Villa Numeris is an independent think tank which promotes a European digital model based on humans. Our mission: to enable decision-makers to understand and anticipate societal and economic transformations, to act accordingly, to raise awareness and to mobilize to give meaning to organizations and succeed in their transformation. Villa Numeris is an association under the 1901 Law financed by its members and by the sale of services. New Culture of Work, Working Differently, Connected Territories, Fake news, Digital citizen, Blockchain, AI, and Citizenship Type: NGO, Think-tanks, Ed, & Culture Activities: it services |
51 | 11 |
|
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … 22 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
6 | 50 |
|
AI signal for builders and business leaders. The noise stops here. Here's why we started aixBrief. Thousands of AI posts flood your feed every day. Most of it is noise. Recycled announcements, vendor hype dressed up as insight, the same "top 10 tools" list reshuffled for the 47th time. If you're a business leader or builder trying to figure out what actually matters in AI for your company, you're on your own. Scrolling, filtering, guessing. We thought that was broken. So we built the filter. aixBrief is a creator-led AI intelligence brand. Every morning we ask one question: out of … 102 similar entities Type: Startup Activities: it services Technologies: SaaS |
45 | 20 |
|
Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic … Type: SMB Activities: consulting healthtech Technologies: Data Analytics |
28 | 136 |
|
Connect. Collaborate. Contribute. Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth … Type: Media |
16 | 4 |
|
Ospedale San Raffaele
There is no cure without research. Within Gruppo San Donato we are a clinical, scientific and university centre of high specialization, since 1971. Our mission of medical and scientific excellence stems from our three-pronged identity. We are a place where Research, Medicine and University Education all meet and work together each and every day. We meet challenges, thanks to our experts who combine their skills to benefit people. Because there is no cure without research. Healthcare, Medicine, Research+, and University Type: Large company |
3 | 4,900 |
|
Active for the future Management that influences tomorrow In 1972 our first Sicav was born, which has since become Epargne Ethique Flexible. 1st sharing fund in Europe created in 1983, launch of our solidarity fund in 2002, range of 100% ISR* funds in 2019, first French management company to adopt the status of mission-driven company in 2020... Ecofi works on a daily basis to combine financial performance and respect for People and the Planet. This commitment has only grown over the years. Today, Ecofi is more than ever focused on the long term, combining control, involvement and sincerity to build, … Type: SMB Activities: fintech Technologies: Decarbonization |
55 | 105 |
|
A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS 46 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 34 |
|
Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: Startup Activities: deeptech Technologies: Synthetic Biology |
8 | 20 |
|
HARNESSING NATURE FOR PEOPLE AND THE PLANET We excel in cell-factory engineering and precision fermentation. Our technology uses microbes found in nature, allowing us to produce a wide array of ingredients such as textile dyes, skincare ingredients and health supplements. Our work today is surrounding our leading product PurePaletteTM. A complete drop in dye replacement for synthetic textile dyes. Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering 85 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology |
6 | 26 |
|
AstronauTx is developing therapeutics to treat neurological disorders by improving sleep architecture. At AstronauTx our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable risk factor for chronic neurodegeneration. We have a unique portfolio of small-molecule therapeutics to restore dysregulated sleep physiology correcting sleep architecture to both improve symptoms and modify neurological disease progression. 35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
3 | 20 |
|
NVCA's 501(c)(3) nonprofit arm expanding, educating, and empowering a vibrant VC investor community. Venture Forward, NVCA’s 501(c)(3) nonprofit arm, is on a mission to democratize access to the venture capital (VC) industry, empower individuals from all backgrounds and geographies to thrive as investors, and equip future VC leaders with the tools for long-term success. We support emerging fund managers and investors by providing education, mentorship, and resources to advance their careers. We are committed to driving healthy and sustainable generational change within established VC firms, ensuring strong industry stewardship for the future. Through these efforts, we envision a VC industry … Type: Incubators & VCs |
18 | 25 |
|
Youandlaw is the law firm specialized in the entrepreneurship sector. Youandlaw is the law firm specialized in the entrepreneurship sector. We speak the language of our clients with close, rigorous and flexible advice. Experts in accompanying startups and funds with our advice during their financing rounds. Commercial, Industrial and Intellectual Property, Privacy, Conflict Resolution, and New Technologies 70 similar entities Type: SMB Activities: legaltech Technologies: IoT |
34 | 9 |
|
Patient-centered cancer precision medicine Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and drug discovery. Our ultimate goal is to optimally allocate approved treatments to cancer patients who will benefit from them, while creating novel therapies that are purpose-designed for patients who don't respond to available treatments. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples with matched blood into 3D immune-microtumors to test potential treatment options and combinations ex vivo. … 26 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
3 | 10 |
|
We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work 116 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
11 | 13 |
|
LallianSe - Life Sciences Integrator
Turning health innovations into economic successes LallianSe was created a decade ago to reverse the situation where, despite our scientific and technological excellence, a very limited number of medical innovations deliver concrete benefits to patients. How can we bridge this persistent gap between research, clinical benefits, and sustainable business models ? As a life sciences Integrator, our mission is to turn innovations into economic successes. We design and pilot tailor-made journeys for ambitious project leaders—institutions, companies, healthcare professionals, and entrepreneurs— through an active, agile, and deeply engaged approach. Since inception, we have supported more than 100 companies by mobilizing a … Type: Incubators & VCs |
19 | 6 |
|
Covering the global community of French startups, entrepreneurs, VCs, and innovators. The French Tech Journal is a newsletter dedicated to covering the dynamic global ecosystem of French entrepreneurs and investors. Type: Media |
67 | 3 |
|
Shine Match & Deal EuroQuity is a service by Bpifrance, France's national investment bank, financing businesses through loans, guarantees, equity investments, and export insurances. Created in 2008, EuroQuity is an online matchmaking platform that helps companies meet investors and partners. EuroQuity is one of the leading matchmaking platforms in Europe while becoming increasingly present in Africa. We provide many additional services such as acceleration programs funded by the European Commission, digital training, coaching sessions, and exclusive online pitch sessions for the most promising companies. In short, EuroQuity is the perfect match for companies to scale with confidence and speed and … Type: Public |
83 | 3 |
|
iXO Private Equity. Invest, Invest, Succeed, Together iXO Private Equity is a management company which mainly carries out LBO and development capital transactions. Its team is made up of 19 people, including 14 professional investors with complementary experience. iXO Private Equity is one of the largest independent French players in the small and mid-cap sector. The management company, based in Toulouse, now manages more than €610 million in assets and invests between €2 and €15 million in equity per project, primarily in companies in the greater South of France and Rhône-Alpes. Type: Incubators & VCs |
51 | 31 |
|
For people and the planet - delivering transformational infrastructure, for the long term. Meridiam was founded in 2005 by Thierry Déau, with the belief that the alignment of interests between the public and private sector can provide critical solutions to the collective needs of communities. Meridiam is an independent investment Benefit Corporation and an asset manager. The firm specializes in the development, financing, and long-term management of sustainable public infrastructure in three core sectors - sustainable mobility, critical public services and innovative low carbon solutions - and invests in sustainable SMEs in Europe. With offices in Addis Ababa, Amman, Dakar, … Type: SMB Activities: fintech govtech Technologies: Decarbonization |
93 | 427 |
|
The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage €4.8 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion/Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our teams, based on … Type: Incubators & VCs |
55 | 153 |
|
Discovering and developing transformative therapeutics for neurodegenerative diseases Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe. We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases. Our name reflects this focus: Muna means ‘to remember’ in Old Norse. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 55 |